Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (461-470 of 1,253) with videos related to

Pageof 126
Sort By:
Preventing Chronic Disease|July 15, 2021
Efficacy of Hypertension Self-Management Classes Among Patients at a Federally Qualified Health CenterCameron Eck, Holly Biola, Tiffany Hayes, et al.
Clinical Trials (London, England)|March 19, 2019
Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials programJay S Shavadia, Abhinav Sharma, Xiangqiong Gu, et al.
European Heart Journal|March 28, 2024
Cardiac implantable electronic devices and bloodstream infections: management and outcomesTardu Özkartal, Andrea Demarchi, Giulio Conte, et al.
Plos One|January 27, 2021
A qualitative, grounded theory exploration of the determinants of self-care behavior among Indian patients with a lived experience of chronic heart failureDeepak Y Kamath, K B Bhuvana, Luke Joshua Salazar, et al.
Journal of Medical Systems|May 28, 2010
Economic assessment of thrombocytopenia: CATCH RegistryEric L Eisenstein, Emily F Honeycutt, Kevin J Anstrom, et al.
European Heart Journal|March 6, 2008
Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudyMichael A McDonald, Yuling Fu, Uwe Zeymer, et al.
American Heart Journal|April 25, 2007
Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meetingE Marc Jolicoeur, Christopher B Granger, John L Fakunding, et al.
American Heart Journal|June 2, 2007
Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)David Brieger, Frans Van de Werf, Alvaro Avezum, et al.
Journal of the American College of Cardiology|May 16, 2006
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programLars G Olsson, Karl Swedberg, Anique Ducharme, et al.
Circulation. Cardiovascular Quality and Outcomes|March 18, 2010
Cognitive function and anticoagulation control in patients with atrial fibrillationGreg C Flaker, Janice Pogue, Salim Yusuf, et al.
Pageof 126

Showing results (461-470 of 1,253) with videos related to

Sort By:
Pageof 126
Preventing Chronic Disease|July 15, 2021
Efficacy of Hypertension Self-Management Classes Among Patients at a Federally Qualified Health CenterCameron Eck, Holly Biola, Tiffany Hayes, et al.
Clinical Trials (London, England)|March 19, 2019
Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials programJay S Shavadia, Abhinav Sharma, Xiangqiong Gu, et al.
European Heart Journal|March 28, 2024
Cardiac implantable electronic devices and bloodstream infections: management and outcomesTardu Özkartal, Andrea Demarchi, Giulio Conte, et al.
Plos One|January 27, 2021
A qualitative, grounded theory exploration of the determinants of self-care behavior among Indian patients with a lived experience of chronic heart failureDeepak Y Kamath, K B Bhuvana, Luke Joshua Salazar, et al.
Journal of Medical Systems|May 28, 2010
Economic assessment of thrombocytopenia: CATCH RegistryEric L Eisenstein, Emily F Honeycutt, Kevin J Anstrom, et al.
European Heart Journal|March 6, 2008
Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudyMichael A McDonald, Yuling Fu, Uwe Zeymer, et al.
American Heart Journal|April 25, 2007
Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meetingE Marc Jolicoeur, Christopher B Granger, John L Fakunding, et al.
American Heart Journal|June 2, 2007
Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)David Brieger, Frans Van de Werf, Alvaro Avezum, et al.
Journal of the American College of Cardiology|May 16, 2006
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programLars G Olsson, Karl Swedberg, Anique Ducharme, et al.
Circulation. Cardiovascular Quality and Outcomes|March 18, 2010
Cognitive function and anticoagulation control in patients with atrial fibrillationGreg C Flaker, Janice Pogue, Salim Yusuf, et al.
Pageof 126